Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-31 Option Award | 2023-04-04 4:38 pm | N/A 2033-03-31 | Acorda Therapeutics Inc. | ACOR | Belloff Neil S. General Counsel and Corp Secy | 77,300 | $0 | 77,300 (Direct) | View |
| 2021-11-08 Option Award | 2021-11-09 7:03 pm | N/A 2031-11-08 | ACORDA THERAPEUTICS INC | ACOR | Belloff Neil S. General Counsel | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-07-30 Tax Withholding | 2021-07-30 8:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 459 | $1.32 | 42,074 (Direct) | View |
| 2021-07-30 Exercise | 2021-07-30 8:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,563 | $0 | 42,074 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-26 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 6,250 | $0 | 100,345 (Direct) | View |
| 2021-05-25 Tax Withholding | 2021-05-26 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,835 | $1.39 | 100,345 (Direct) | View |
| 2021-04-30 Tax Withholding | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 459 | $2.18 | 38,118 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,562 | $0 | 38,118 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 7,338 | $3.95 | 101,077 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 25,000 | $0 | 101,077 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:40 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,563 | $0 | 20,915 (Direct) | View |
| 2021-01-30 Tax Withholding | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 542 | $3.44 | 20,915 (Direct) | View |
| 2020-10-30 Tax Withholding | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 459 | $2.53 | 21,457 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,562 | $0 | 21,457 (Direct) | View |
| 2020-07-30 Exercise | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,563 | $0 | 21,916 (Direct) | View |
| 2020-07-30 Tax Withholding | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 459 | $2.84 | 21,916 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 459 | $2.92 | 22,375 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,562 | $0 | 22,375 (Direct) | View |
| 2020-01-30 Exercise(A) | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 6,250 | $0 | 22,834 (Direct) | View |
| 2020-01-30 Tax Withholding(A) | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 2,166 | $3.91 | 22,834 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:01 pm | N/A 2030-02-25 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | 6,250 | $0 | 22,834 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | 2,166 | $3.91 | 22,834 (Direct) | View |